GENOPTIX INC Earnings Conference Call (Q1 2008) Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other May 8 Calls
Today's Calls
Call Details
GENOPTIX INC Earnings Conference Call (Q1 2008)
Thu, May 8, 2008, 5:00 pm Eastern

Listen to the archived event audio


About GENOPTIX INC (NasdaqGM:GXDX)
Genoptix, Inc. provides specialized laboratory service that focus on delivering customized and collaborative diagnostic services. Its services include COMPASS service offering, in which the company’s hematopathologists determine the appropriate diagnostic tests to be performed, and then integrates patient history and all previous and current test results into a comprehensive diagnostic report; and CHART service offering, in which the hematologists and oncologists receives a detailed assessment of a patient's disease progression over time. The company also offers multiple diagnostic services, such as professional interpretation by its hematopathologists. It focuses on marketing its specialized diagnostic services to community-based hematologists and oncologists treating malignancies of the blood and bone marrow, and other forms of cancer. The company was founded in 1999 and is based in Carlsbad, California.


More Info: Quote | Profile | Reports | Research | Insider | Financials | Analyst Ratings


Copyright © 2008 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2008 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.